GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Cyclically Adjusted Book per Share

HLB Therapeutics Co (XKRX:115450) Cyclically Adjusted Book per Share : ₩1,383.61 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

HLB Therapeutics Co's adjusted book value per share for the three months ended in Mar. 2024 was ₩2,199.742. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩1,383.61 for the trailing ten years ended in Mar. 2024.

During the past 12 months, HLB Therapeutics Co's average Cyclically Adjusted Book Growth Rate was 15.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of HLB Therapeutics Co was 9.50% per year. The lowest was -0.10% per year. And the median was 4.70% per year.

As of today (2024-05-26), HLB Therapeutics Co's current stock price is ₩8190.00. HLB Therapeutics Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩1,383.61. HLB Therapeutics Co's Cyclically Adjusted PB Ratio of today is 5.92.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HLB Therapeutics Co was 13.64. The lowest was 2.27. And the median was 5.85.


HLB Therapeutics Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for HLB Therapeutics Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Cyclically Adjusted Book per Share Chart

HLB Therapeutics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,157.50 1,025.88 985.78 1,152.61 1,346.57

HLB Therapeutics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,201.71 1,246.81 1,307.12 1,346.57 1,383.61

Competitive Comparison of HLB Therapeutics Co's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, HLB Therapeutics Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Therapeutics Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Therapeutics Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where HLB Therapeutics Co's Cyclically Adjusted PB Ratio falls into.



HLB Therapeutics Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HLB Therapeutics Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2199.742/118.8477*118.8477
=2,199.742

Current CPI (Mar. 2024) = 118.8477.

HLB Therapeutics Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 618.614 99.353 739.996
201409 601.668 99.608 717.883
201412 569.267 99.098 682.719
201503 546.516 99.720 651.345
201506 573.849 100.050 681.666
201509 564.202 100.110 669.804
201512 716.249 100.220 849.377
201603 937.713 100.560 1,108.244
201606 854.425 100.790 1,007.505
201609 759.792 101.460 890.001
201612 741.161 101.560 867.323
201703 829.316 102.850 958.311
201706 830.191 102.610 961.566
201709 848.199 103.490 974.070
201712 786.049 102.990 907.079
201803 787.064 104.100 898.566
201806 673.746 104.130 768.973
201809 1,453.494 105.650 1,635.063
201812 1,325.317 104.350 1,509.448
201903 1,370.295 104.490 1,558.584
201906 1,320.307 104.880 1,496.143
201909 1,312.926 105.200 1,483.253
201912 1,208.128 105.120 1,365.898
202003 1,292.359 105.540 1,455.315
202006 1,458.404 104.870 1,652.789
202009 1,558.785 106.200 1,744.426
202012 1,565.508 105.765 1,759.148
202103 1,514.625 107.357 1,676.736
202106 1,434.831 107.579 1,585.133
202109 1,396.436 108.759 1,525.969
202112 1,785.434 109.676 1,934.735
202203 1,794.754 111.806 1,907.794
202206 1,909.804 114.083 1,989.571
202209 1,900.530 114.831 1,967.004
202212 1,779.976 115.200 1,836.334
202303 2,091.008 116.550 2,132.238
202306 2,192.471 117.140 2,224.435
202309 2,197.966 119.111 2,193.104
202312 2,177.021 118.848 2,177.021
202403 2,199.742 118.848 2,199.742

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


HLB Therapeutics Co  (XKRX:115450) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

HLB Therapeutics Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8190.00/1383.61
=5.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HLB Therapeutics Co was 13.64. The lowest was 2.27. And the median was 5.85.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


HLB Therapeutics Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Therapeutics Co (XKRX:115450) Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines